Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus

American Journal of Clinical Nutrition

Volumn 80, Issue 4, 2004, Pages 887-895

  Moloney, Fiona ^a   Yeow, Toh Peng ^b   Mullen, Anne ^a   Nolan, John J ^b   Roche, Helen M ^a,b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

Cardiovascular disease; Conjugated linoleic acid; Diabetes; Glucose; Humans; Inflammation; Insulin sensitivity; Lipoprotein metabolism; Metabolic syndrome; Type 2 diabetes mellitus

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CONJUGATED LINOLEIC ACID; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN;

ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FIBRINOGEN BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN METABOLISM; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; RANDOMIZED CONTROLLED TRIAL; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; BLOOD; DIET RESTRICTION; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR;

ANIMALIA;

ANALYSIS OF VARIANCE; AREA UNDER CURVE; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION; INSULIN; LINOLEIC ACIDS, CONJUGATED; LIPOPROTEINS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 5144228885     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/80.4.887     Document Type: Article

References (55)

1. Hu FB, Van Dam RM, Liu S. Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia 2001;44:805-17.
2. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes Nature 2001;409:307-12.
3. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: part 1: diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
4. Das UN. Is metabolic syndrome X an inflammatory condition? Exp Biol Med (Maywood) 2002;227:989-97.
5. Leinonen E, Hurt-Camejo E, Wiklund O, Hultén LM, Hiukka A, Taskinen MR. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 2003;166:387-94.
6. Erkelens DW. Insulin resistance syndrome and type II diabetes mellitus. Am J Cardiol 2001;88(suppl):J38-42.
7. Roche HM, Noone E, Sewter C, et al. Isomer dependent metabolic effects of conjugated linoleic acid (CLA), insights from molecular markers: SREBP-1c and LXRα. Diabetes 2002;51:2037-44.
8. Gavino VC, Gavino G, Leblanc MJ, Tuchweber B. An isomeric mixture of conjugated linoleic acids but not pure cis-9, trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters. J Nutr 2000;130:27-9.
9. Park Y, Albright KL, Liu W, Storkson JM, Cook ME, Pariza MW. Effect of conjugated linoleic acid on body composition in mice. Lipids 1997; 32:853-8.
10. West DB, DeLany JP, Camet PM, Bolhm F, Truett AA, Scimeca JA. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol 1998;275(suppl):R667-72.
11. DeLany JP, Bolhm F, Truett AA, Scimeca JA, West DB. Conjugated linoleic acid reduces body fat content in mice without affecting energy intake. Am J Physiol 1999;276(suppl):R1172-9.
12. Wilson TA, Nicolosi RJ, Chrysam M, Kritchevsky D. Conjugated linoleic acid reduces early aortic atherosclerosis greater than linoleic acid in hypercholesterolemic hamsters. Nutr Res 2000;20:1795-805.
13. Kritchevsky D, Tepper SA, Wright S, Tso P, Czarnecki SK. Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. J Am Coll Nutr 2000;19(suppl):S472-7.
14. Toomey S, Roche H, Fitzgerald D, Belton O. Regression of pre-established atherosclerosis in the apoE-/- mouse by conjugated linoleic acid. Biochem Soc Trans 2003;31:1075-9.
15. Larsen TM, Toubro S, Astrup A. Efficacy and safety of dietary supplements containing conjugated linoleic acid (CLA) for the treatment of obesity - evidence from animal and human studies. J Lipid Res 2003; 44:2234-41.
16. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat in overweight and obese subjects. J Nutr 2000;130:2943-8.
17. Noone E, Roche HM, Nugent AP, Gibney MJ. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 2002;88:243-51.
18. Benito P, Nelson GJ, Kelley DS, Bartolini G, Schmidt PC, Simon V. The effect of conjugated linoleic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 2001;36:221-7.
19. Mougois V, Matsakas A, Petridou A, et al. Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. J Nutr Biochem 2001;12:585-94.
20. Riserus U, Brismar K, Arner P, Veesby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002;25:1516-21.
21. Risérus U, Samar B, Jovinge S, Fredrikson GN, Δrnlöv J, Veesby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated c-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 2002;106:1925-9.
22. Noone E, McBennett S, Gibney MJ, Roche HM. The isomer-specific effects of conjugated linoleic acid on gene expression and lipid metabolism in male Ob/Ob mice. Proc Nutr Soc 2001;60:149A.
23. American Diabetes Association. Evidence-based nutrition principles and recommendation for the treatment and prevention of diabetes and related complications. Diabetes Care 2002;25:202-12.
24. Gregory J, Foster K, Tyler H, Wiseman M. The dietary and nutritional survey of British adults. London: Her Majesty's Stationery Office, 1990.
25. Wallace AJ, McCarthy SN, Gibney MJ. Intakes of saturated, monosaturated and polyunsaturated fat in Irish adults: findings of the North/South Ireland food consumption survey. Proc Nutr Soc 2002;61:85A.
26. Korhonen M, Kastarinen M, Uusitupa M, Puska P, Nissinen A. The effect of intensified diet counseling on the diet of hypertensive subjects in primary health care: a 2-year open randomized controlled trial of lifestyle intervention against hypertension in eastern Finland. Prev Med 2003;36:8-16.
27. Harrington K, Robson PJ, Kiely M, Livingston MBE, Lambe J, Gibney MJ. The North/South Ireland food consumption survey: survey design and methodology. Public Health Nutr 2001;4:1037-42.
28. Jackson K, Robertson MD, Fielding BA, Frayn KN, Williams CM. Olive oil increases the number of triacylglycerol-rich chylomicron particles compared with other oils: an effect retained when a second meal is fed. Am J Clin Nutr 2002;76:942-9.
29. Brustolin D, Maierna M, Aguzzi F, Zoppi F, Tarenghi G, Berti G. Immunoturbidimetric method for routine determinations of apolipoproteins A1 and B. Clin Chem 1991;37:742-7.
30. Norris LA, Joyce M, O'Keeffe N, Sheppard BL, Bonnar J. Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy. Maturitas 2002;25:125-33.
31. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 1957;226: 497-509.
32. Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A. Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr 1998;67:44-9.
33. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990;300:230-5.
34. Allison DB, Paultre F, Maggio C, Mezzitis N, Pi-Sunyer FX. The use of area under curves in diabetes research. Diabetes Care 1995;18:245-50.
35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
36. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10.
37. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-70.
38. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001;24:539-48.
39. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia 2001;4:2107-14.
40. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, et al. Conjugated linoleic acid supplementation reduces adipose tissue by apotosis and develops lipodystrophy in mice. Diabetes 2000;49:1534-42.
41. Houseknecht KL, Vanden Heuvel JP, Moya-Camarena, et al. Dietary conjugated linoleic acid normalises impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 1998; 244:678-82.
42. Ryder JW, Portocarrero CP, Song XM, et al. Isomer-specific antidiabetic properties of conjugated linoleic acid:improved glucose tolerance, skeletal muscle insulin action and UCP-2 gene expression. Diabetes 2001; 50:1149-57.
43. NIH Consensus Statement. Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 1993;269:505-10.
44. Tall AR, Jiang X, Luo Y, Silver D. 1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol 2000;20:1185-8.
45. Autran D, Attia N, Debecjus M, Durlach V, Girard-Globa A. Postprandial reverse cholesterol transport in type 2 diabetic patients: effect of lipid lowering treatment. Atherosclerosis 2000;153:453-60.
46. Rader DJ, Davidson MH, Caplan RJ, Pears JS. Lipid and lipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin. Am J Cardiol 2003;91(A):20C-3C.
47. Smedman A, Veesby B. Conjugated linoleic acid supplementation in humans-metabolic effects. Lipids 2001;36:773-81.
48. Christ ER, Carroll PV, Albany E, et al. Normal VLDL metabolism despite altered lipoprotein composition in type I diabetes mellitus. Clin Endocrinol 2001;55:777-87.
49. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue. Arterioscler Thromb Vasc Biol 1999;19:972-8.
50. Frohlich J, Steiner G. Dyslipidaemia and coagulation defects of insulin resistance. Int J Clin Pract 2000;113(suppl):14-22.
51. Norris LA. Blood coagulation. Best Pract Res Clin Obstet Gynaecol 2003;17:369-83.
52. Jiang J, Wolk A, Veesby B. Relation between the intake of milk fat and the occurrence of conjugated linoleic acid in human adipose tissue. Am J Clin Nutr 1999;70:21-7.
53. Britton M, Fong C, Wickens D, Yudkin J. Diet as a source of phospholipid esterified 9,11-octadecadienoic acid in humans. Clin Sci 1992;83: 97-101.
54. Martin JC, Gregoire S, Siess MH, et al. Effects of conjugated linoleic acid isomers on lipid metabolising enzymes in male rats. Lipids 2000; 35:91-8.
55. Sebedio JL, Juaneda P, Dobson G, et al. Metabolites of conjugated isomers of linoleic acid (CLA) in the rat. Biochim Biophys Acta 1997; 1345:5-10.